| Hi E, Recruitment and enrollment is the core of a successful clinical trial. But are we truly serving the population we strive to heal? What can we do better to ensure that our trials are an accurate reflection of the people who need the medicine we are testing?
Rho experts, Yael Symes, PhD, MSP, Integrated Product Development Associate and Jack Modell, MD, Vice President and Senior Medical Officer share their knowledge and research on improving diversity in clinical trials in their article, "What Drug Development Sponsors, Contract Research Organizations, and Investigators Can Do to Increase Diversity in Clinical Trials" in the recently published October issue of The Journal of Clinical Pharmacology. It illuminates who is participating in clinical trials and why, in addition to exploring why diversity in clinical research is important for ethical, scientific, and financial reasons. As Dr. Symes states, “Recruiting diverse clinical trial populations is good science.” |
